Evidence map›Paper›PMID 18492780›Full record

ReviewAmerican journal of physiology. Endocrinology and metabolism2008

Calpain activity and muscle wasting in sepsis.

Ira J Smith, Stewart H Lecker, Per-Olof Hasselgren

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Endocrinology and metabolism, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 135 citations in OpenAlex.

  1. Article
  2. Research progress on the mechanism of FOXO protein in sepsis.Apoptosis : an international journal on programmed cell death · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Observational
  9. Intensive care unit-acquired weakness: Recent insights.Journal of intensive medicine · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. European journal of translational myology · 2019
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ira J SmithDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Stewart H Lecker
Per-Olof Hasselgren
Beth Israel Deaconess Medical Center · US

Funding

MUSCLE PROTEIN TURNOVER AND AMINO ACID UPTAKE IN SEPSISR01DK037908 · NIDDK · UNIVERSITY OF CINCINNATI · PI HASSELGREN, PER-OLOF J · 1987 to 2010
$2.6M
C/EBP, atrogin-1, and muscle wastingR01NR008545 · NINR · BETH ISRAEL DEACONESS MEDICAL CENTER · PI HASSELGREN, PER-OLOF J · 2004 to 2008
$1.8M
NIDDK NIH HHS R01-DK-37908NINR NIH HHS R01-NR-08545PHS HHS R01-D-62307
6 · The paper itself

Abstract

Muscle wasting in sepsis reflects activation of multiple proteolytic mechanisms, including lyosomal and ubiquitin-proteasome-dependent protein breakdown. Recent studies suggest that activation of the calpain system also plays an important role in sepsis-induced muscle wasting. Perhaps the most important consequence of calpain activation in skeletal muscle during sepsis is disruption of the sarcomere, allowing for the release of myofilaments (including actin and myosin) that are subsequently ubiquitinated and degraded by the 26S proteasome. Other important consequences of calpain activation that may contribute to muscle wasting during sepsis include degradation of certain transcription factors and nuclear cofactors, activation of the 26S proteasome, and inhibition of Akt activity, allowing for downstream activation of Foxo transcription factors and GSK-3beta. The role of calpain activation in sepsis-induced muscle wasting suggests that the calpain system may be a therapeutic target in the prevention and treatment of muscle wasting during sepsis. Furthermore, because calpain activation may also be involved in muscle wasting caused by other conditions, including different muscular dystrophies and cancer, calpain inhibitors may be beneficial not only in the treatment of sepsis-induced muscle wasting but in other conditions causing muscle atrophy as well.

Indexed as

AnimalsCalciumCalpainHumansMuscle, SkeletalProto-Oncogene Proteins c-aktSarcomeresSepsisTranscription FactorsWasting SyndromeCalciumCalpainProto-Oncogene Proteins c-aktTranscription Factors

Identifiers

PMID18492780
PMCPMC2575901
OpenAlexW2096754758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.